The Lancet Regional Health – Western Pacific-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2272447, encodeId=131c22e2447ba, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：这个期刊审稿从投稿到发表的周期一般多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=945f9328796, createdName=ms9000001244919142, createdTime=Tue Jul 08 00:54:44 CST 2025, time=2025-07-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2200297, encodeId=a677220029ed8, content=这个杂志有希望破10吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=Dr Young, createdTime=Thu Apr 25 10:15:44 CST 2024, time=2024-04-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2141847, encodeId=dbd8214184eb2, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：妇产科学;生育健康 经验分享：4.26 投稿 4.29 under review 中间状态变为 with editor, under review, required reviews completed,under review 5.28 required reviews completed，目前该持续近两周 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ca8289510, createdName=ms8000000261515096, createdTime=Fri Jun 09 10:50:18 CST 2023, time=2023-06-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2170791, encodeId=729821e0791d1, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心血管 经验分享：还没投，不知道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24268459349, createdName=ms9000001322752373, createdTime=Fri Nov 24 17:12:52 CST 2023, time=2023-11-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2100279, encodeId=80a121002e986, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：送审5-6位专家，意见给的都挺多，挺中肯。editor处理速度挺快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5e3064566, createdName=3120102952, createdTime=Sun Nov 13 16:11:14 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110606, encodeId=fd2f11106067e, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=605, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:54 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226206, encodeId=5cd51226206ca, content=Plagiarism check 投稿时这个选项是必须要填的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44d08201428, createdName=ms7000001023316259, createdTime=Mon Jun 13 17:39:32 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227148, encodeId=e940122e148b0, content=这个会进sci吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac0d5397053, createdName=小月小月, createdTime=Sat Jun 18 07:12:01 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226209, encodeId=fa6f12262097f, content=投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44d08201428, createdName=ms7000001023316259, createdTime=Mon Jun 13 17:40:14 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110605, encodeId=fc751110605c1, content=RUNINGTITLE是必须的么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=512, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:54 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2025-07-08 ms9000001244919142 来自广东省

审稿速度:6.0 | 投稿命中率:25.0
经验分享：这个期刊审稿从投稿到发表的周期一般多久呀

4 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2272447, encodeId=131c22e2447ba, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：这个期刊审稿从投稿到发表的周期一般多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=945f9328796, createdName=ms9000001244919142, createdTime=Tue Jul 08 00:54:44 CST 2025, time=2025-07-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2200297, encodeId=a677220029ed8, content=这个杂志有希望破10吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=Dr Young, createdTime=Thu Apr 25 10:15:44 CST 2024, time=2024-04-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2141847, encodeId=dbd8214184eb2, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：妇产科学;生育健康 经验分享：4.26 投稿 4.29 under review 中间状态变为 with editor, under review, required reviews completed,under review 5.28 required reviews completed，目前该持续近两周 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ca8289510, createdName=ms8000000261515096, createdTime=Fri Jun 09 10:50:18 CST 2023, time=2023-06-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2170791, encodeId=729821e0791d1, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心血管 经验分享：还没投，不知道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24268459349, createdName=ms9000001322752373, createdTime=Fri Nov 24 17:12:52 CST 2023, time=2023-11-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2100279, encodeId=80a121002e986, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：送审5-6位专家，意见给的都挺多，挺中肯。editor处理速度挺快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5e3064566, createdName=3120102952, createdTime=Sun Nov 13 16:11:14 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110606, encodeId=fd2f11106067e, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=605, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:54 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226206, encodeId=5cd51226206ca, content=Plagiarism check 投稿时这个选项是必须要填的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44d08201428, createdName=ms7000001023316259, createdTime=Mon Jun 13 17:39:32 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227148, encodeId=e940122e148b0, content=这个会进sci吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac0d5397053, createdName=小月小月, createdTime=Sat Jun 18 07:12:01 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226209, encodeId=fa6f12262097f, content=投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44d08201428, createdName=ms7000001023316259, createdTime=Mon Jun 13 17:40:14 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110605, encodeId=fc751110605c1, content=RUNINGTITLE是必须的么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=512, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:54 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2024-04-25 Dr Young 来自北京

这个杂志有希望破10吗

144 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2272447, encodeId=131c22e2447ba, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：这个期刊审稿从投稿到发表的周期一般多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=945f9328796, createdName=ms9000001244919142, createdTime=Tue Jul 08 00:54:44 CST 2025, time=2025-07-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2200297, encodeId=a677220029ed8, content=这个杂志有希望破10吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=Dr Young, createdTime=Thu Apr 25 10:15:44 CST 2024, time=2024-04-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2141847, encodeId=dbd8214184eb2, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：妇产科学;生育健康 经验分享：4.26 投稿 4.29 under review 中间状态变为 with editor, under review, required reviews completed,under review 5.28 required reviews completed，目前该持续近两周 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ca8289510, createdName=ms8000000261515096, createdTime=Fri Jun 09 10:50:18 CST 2023, time=2023-06-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2170791, encodeId=729821e0791d1, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心血管 经验分享：还没投，不知道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24268459349, createdName=ms9000001322752373, createdTime=Fri Nov 24 17:12:52 CST 2023, time=2023-11-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2100279, encodeId=80a121002e986, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：送审5-6位专家，意见给的都挺多，挺中肯。editor处理速度挺快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5e3064566, createdName=3120102952, createdTime=Sun Nov 13 16:11:14 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110606, encodeId=fd2f11106067e, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=605, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:54 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226206, encodeId=5cd51226206ca, content=Plagiarism check 投稿时这个选项是必须要填的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44d08201428, createdName=ms7000001023316259, createdTime=Mon Jun 13 17:39:32 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227148, encodeId=e940122e148b0, content=这个会进sci吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac0d5397053, createdName=小月小月, createdTime=Sat Jun 18 07:12:01 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226209, encodeId=fa6f12262097f, content=投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44d08201428, createdName=ms7000001023316259, createdTime=Mon Jun 13 17:40:14 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110605, encodeId=fc751110605c1, content=RUNINGTITLE是必须的么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=512, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:54 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2023-06-09 ms8000000261515096 来自北京

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：妇产科学;生育健康
经验分享：4.26 投稿
4.29 under review
中间状态变为 with editor, under review, required reviews completed,under review
5.28 required reviews completed，目前该持续近两周

199 5 举报

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2272447, encodeId=131c22e2447ba, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：这个期刊审稿从投稿到发表的周期一般多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=945f9328796, createdName=ms9000001244919142, createdTime=Tue Jul 08 00:54:44 CST 2025, time=2025-07-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2200297, encodeId=a677220029ed8, content=这个杂志有希望破10吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=Dr Young, createdTime=Thu Apr 25 10:15:44 CST 2024, time=2024-04-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2141847, encodeId=dbd8214184eb2, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：妇产科学;生育健康 经验分享：4.26 投稿 4.29 under review 中间状态变为 with editor, under review, required reviews completed,under review 5.28 required reviews completed，目前该持续近两周 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ca8289510, createdName=ms8000000261515096, createdTime=Fri Jun 09 10:50:18 CST 2023, time=2023-06-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2170791, encodeId=729821e0791d1, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心血管 经验分享：还没投，不知道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24268459349, createdName=ms9000001322752373, createdTime=Fri Nov 24 17:12:52 CST 2023, time=2023-11-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2100279, encodeId=80a121002e986, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：送审5-6位专家，意见给的都挺多，挺中肯。editor处理速度挺快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5e3064566, createdName=3120102952, createdTime=Sun Nov 13 16:11:14 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110606, encodeId=fd2f11106067e, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=605, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:54 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226206, encodeId=5cd51226206ca, content=Plagiarism check 投稿时这个选项是必须要填的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44d08201428, createdName=ms7000001023316259, createdTime=Mon Jun 13 17:39:32 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227148, encodeId=e940122e148b0, content=这个会进sci吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac0d5397053, createdName=小月小月, createdTime=Sat Jun 18 07:12:01 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226209, encodeId=fa6f12262097f, content=投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44d08201428, createdName=ms7000001023316259, createdTime=Mon Jun 13 17:40:14 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110605, encodeId=fc751110605c1, content=RUNINGTITLE是必须的么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=512, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:54 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2023-11-24 ms9000001322752373 来自上海

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：心血管
经验分享：还没投，不知道

142 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2272447, encodeId=131c22e2447ba, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：这个期刊审稿从投稿到发表的周期一般多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=945f9328796, createdName=ms9000001244919142, createdTime=Tue Jul 08 00:54:44 CST 2025, time=2025-07-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2200297, encodeId=a677220029ed8, content=这个杂志有希望破10吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=Dr Young, createdTime=Thu Apr 25 10:15:44 CST 2024, time=2024-04-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2141847, encodeId=dbd8214184eb2, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：妇产科学;生育健康 经验分享：4.26 投稿 4.29 under review 中间状态变为 with editor, under review, required reviews completed,under review 5.28 required reviews completed，目前该持续近两周 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ca8289510, createdName=ms8000000261515096, createdTime=Fri Jun 09 10:50:18 CST 2023, time=2023-06-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2170791, encodeId=729821e0791d1, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心血管 经验分享：还没投，不知道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24268459349, createdName=ms9000001322752373, createdTime=Fri Nov 24 17:12:52 CST 2023, time=2023-11-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2100279, encodeId=80a121002e986, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：送审5-6位专家，意见给的都挺多，挺中肯。editor处理速度挺快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5e3064566, createdName=3120102952, createdTime=Sun Nov 13 16:11:14 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110606, encodeId=fd2f11106067e, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=605, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:54 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226206, encodeId=5cd51226206ca, content=Plagiarism check 投稿时这个选项是必须要填的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44d08201428, createdName=ms7000001023316259, createdTime=Mon Jun 13 17:39:32 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227148, encodeId=e940122e148b0, content=这个会进sci吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac0d5397053, createdName=小月小月, createdTime=Sat Jun 18 07:12:01 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226209, encodeId=fa6f12262097f, content=投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44d08201428, createdName=ms7000001023316259, createdTime=Mon Jun 13 17:40:14 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110605, encodeId=fc751110605c1, content=RUNINGTITLE是必须的么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=512, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:54 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2022-11-13 3120102952

审稿速度:1.0 | 投稿命中率:25.0
经验分享：送审5-6位专家，意见给的都挺多，挺中肯。editor处理速度挺快。

262 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2272447, encodeId=131c22e2447ba, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：这个期刊审稿从投稿到发表的周期一般多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=945f9328796, createdName=ms9000001244919142, createdTime=Tue Jul 08 00:54:44 CST 2025, time=2025-07-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2200297, encodeId=a677220029ed8, content=这个杂志有希望破10吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=Dr Young, createdTime=Thu Apr 25 10:15:44 CST 2024, time=2024-04-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2141847, encodeId=dbd8214184eb2, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：妇产科学;生育健康 经验分享：4.26 投稿 4.29 under review 中间状态变为 with editor, under review, required reviews completed,under review 5.28 required reviews completed，目前该持续近两周 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ca8289510, createdName=ms8000000261515096, createdTime=Fri Jun 09 10:50:18 CST 2023, time=2023-06-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2170791, encodeId=729821e0791d1, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心血管 经验分享：还没投，不知道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24268459349, createdName=ms9000001322752373, createdTime=Fri Nov 24 17:12:52 CST 2023, time=2023-11-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2100279, encodeId=80a121002e986, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：送审5-6位专家，意见给的都挺多，挺中肯。editor处理速度挺快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5e3064566, createdName=3120102952, createdTime=Sun Nov 13 16:11:14 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110606, encodeId=fd2f11106067e, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=605, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:54 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226206, encodeId=5cd51226206ca, content=Plagiarism check 投稿时这个选项是必须要填的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44d08201428, createdName=ms7000001023316259, createdTime=Mon Jun 13 17:39:32 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227148, encodeId=e940122e148b0, content=这个会进sci吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac0d5397053, createdName=小月小月, createdTime=Sat Jun 18 07:12:01 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226209, encodeId=fa6f12262097f, content=投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44d08201428, createdName=ms7000001023316259, createdTime=Mon Jun 13 17:40:14 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110605, encodeId=fc751110605c1, content=RUNINGTITLE是必须的么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=512, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:54 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2021-12-27 学医的彭于晏

RUNNINGTITLE和TITLE的区别？

605 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2272447, encodeId=131c22e2447ba, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：这个期刊审稿从投稿到发表的周期一般多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=945f9328796, createdName=ms9000001244919142, createdTime=Tue Jul 08 00:54:44 CST 2025, time=2025-07-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2200297, encodeId=a677220029ed8, content=这个杂志有希望破10吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=Dr Young, createdTime=Thu Apr 25 10:15:44 CST 2024, time=2024-04-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2141847, encodeId=dbd8214184eb2, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：妇产科学;生育健康 经验分享：4.26 投稿 4.29 under review 中间状态变为 with editor, under review, required reviews completed,under review 5.28 required reviews completed，目前该持续近两周 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ca8289510, createdName=ms8000000261515096, createdTime=Fri Jun 09 10:50:18 CST 2023, time=2023-06-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2170791, encodeId=729821e0791d1, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心血管 经验分享：还没投，不知道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24268459349, createdName=ms9000001322752373, createdTime=Fri Nov 24 17:12:52 CST 2023, time=2023-11-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2100279, encodeId=80a121002e986, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：送审5-6位专家，意见给的都挺多，挺中肯。editor处理速度挺快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5e3064566, createdName=3120102952, createdTime=Sun Nov 13 16:11:14 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110606, encodeId=fd2f11106067e, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=605, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:54 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226206, encodeId=5cd51226206ca, content=Plagiarism check 投稿时这个选项是必须要填的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44d08201428, createdName=ms7000001023316259, createdTime=Mon Jun 13 17:39:32 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227148, encodeId=e940122e148b0, content=这个会进sci吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac0d5397053, createdName=小月小月, createdTime=Sat Jun 18 07:12:01 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226209, encodeId=fa6f12262097f, content=投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44d08201428, createdName=ms7000001023316259, createdTime=Mon Jun 13 17:40:14 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110605, encodeId=fc751110605c1, content=RUNINGTITLE是必须的么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=512, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:54 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2022-06-13 ms7000001023316259

Plagiarism check 投稿时这个选项是必须要填的吗

324 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2272447, encodeId=131c22e2447ba, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：这个期刊审稿从投稿到发表的周期一般多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=945f9328796, createdName=ms9000001244919142, createdTime=Tue Jul 08 00:54:44 CST 2025, time=2025-07-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2200297, encodeId=a677220029ed8, content=这个杂志有希望破10吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=Dr Young, createdTime=Thu Apr 25 10:15:44 CST 2024, time=2024-04-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2141847, encodeId=dbd8214184eb2, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：妇产科学;生育健康 经验分享：4.26 投稿 4.29 under review 中间状态变为 with editor, under review, required reviews completed,under review 5.28 required reviews completed，目前该持续近两周 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ca8289510, createdName=ms8000000261515096, createdTime=Fri Jun 09 10:50:18 CST 2023, time=2023-06-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2170791, encodeId=729821e0791d1, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心血管 经验分享：还没投，不知道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24268459349, createdName=ms9000001322752373, createdTime=Fri Nov 24 17:12:52 CST 2023, time=2023-11-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2100279, encodeId=80a121002e986, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：送审5-6位专家，意见给的都挺多，挺中肯。editor处理速度挺快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5e3064566, createdName=3120102952, createdTime=Sun Nov 13 16:11:14 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110606, encodeId=fd2f11106067e, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=605, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:54 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226206, encodeId=5cd51226206ca, content=Plagiarism check 投稿时这个选项是必须要填的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44d08201428, createdName=ms7000001023316259, createdTime=Mon Jun 13 17:39:32 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227148, encodeId=e940122e148b0, content=这个会进sci吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac0d5397053, createdName=小月小月, createdTime=Sat Jun 18 07:12:01 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226209, encodeId=fa6f12262097f, content=投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44d08201428, createdName=ms7000001023316259, createdTime=Mon Jun 13 17:40:14 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110605, encodeId=fc751110605c1, content=RUNINGTITLE是必须的么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=512, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:54 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2022-06-18 小月小月

这个会进sci吗

345 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2272447, encodeId=131c22e2447ba, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：这个期刊审稿从投稿到发表的周期一般多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=945f9328796, createdName=ms9000001244919142, createdTime=Tue Jul 08 00:54:44 CST 2025, time=2025-07-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2200297, encodeId=a677220029ed8, content=这个杂志有希望破10吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=Dr Young, createdTime=Thu Apr 25 10:15:44 CST 2024, time=2024-04-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2141847, encodeId=dbd8214184eb2, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：妇产科学;生育健康 经验分享：4.26 投稿 4.29 under review 中间状态变为 with editor, under review, required reviews completed,under review 5.28 required reviews completed，目前该持续近两周 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ca8289510, createdName=ms8000000261515096, createdTime=Fri Jun 09 10:50:18 CST 2023, time=2023-06-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2170791, encodeId=729821e0791d1, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心血管 经验分享：还没投，不知道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24268459349, createdName=ms9000001322752373, createdTime=Fri Nov 24 17:12:52 CST 2023, time=2023-11-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2100279, encodeId=80a121002e986, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：送审5-6位专家，意见给的都挺多，挺中肯。editor处理速度挺快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5e3064566, createdName=3120102952, createdTime=Sun Nov 13 16:11:14 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110606, encodeId=fd2f11106067e, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=605, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:54 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226206, encodeId=5cd51226206ca, content=Plagiarism check 投稿时这个选项是必须要填的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44d08201428, createdName=ms7000001023316259, createdTime=Mon Jun 13 17:39:32 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227148, encodeId=e940122e148b0, content=这个会进sci吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac0d5397053, createdName=小月小月, createdTime=Sat Jun 18 07:12:01 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226209, encodeId=fa6f12262097f, content=投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44d08201428, createdName=ms7000001023316259, createdTime=Mon Jun 13 17:40:14 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110605, encodeId=fc751110605c1, content=RUNINGTITLE是必须的么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=512, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:54 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2022-06-13 ms7000001023316259

投稿

335 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2272447, encodeId=131c22e2447ba, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：这个期刊审稿从投稿到发表的周期一般多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=945f9328796, createdName=ms9000001244919142, createdTime=Tue Jul 08 00:54:44 CST 2025, time=2025-07-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2200297, encodeId=a677220029ed8, content=这个杂志有希望破10吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=Dr Young, createdTime=Thu Apr 25 10:15:44 CST 2024, time=2024-04-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2141847, encodeId=dbd8214184eb2, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：妇产科学;生育健康 经验分享：4.26 投稿 4.29 under review 中间状态变为 with editor, under review, required reviews completed,under review 5.28 required reviews completed，目前该持续近两周 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ca8289510, createdName=ms8000000261515096, createdTime=Fri Jun 09 10:50:18 CST 2023, time=2023-06-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2170791, encodeId=729821e0791d1, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心血管 经验分享：还没投，不知道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24268459349, createdName=ms9000001322752373, createdTime=Fri Nov 24 17:12:52 CST 2023, time=2023-11-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2100279, encodeId=80a121002e986, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：送审5-6位专家，意见给的都挺多，挺中肯。editor处理速度挺快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5e3064566, createdName=3120102952, createdTime=Sun Nov 13 16:11:14 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110606, encodeId=fd2f11106067e, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=605, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:54 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226206, encodeId=5cd51226206ca, content=Plagiarism check 投稿时这个选项是必须要填的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44d08201428, createdName=ms7000001023316259, createdTime=Mon Jun 13 17:39:32 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227148, encodeId=e940122e148b0, content=这个会进sci吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac0d5397053, createdName=小月小月, createdTime=Sat Jun 18 07:12:01 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226209, encodeId=fa6f12262097f, content=投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44d08201428, createdName=ms7000001023316259, createdTime=Mon Jun 13 17:40:14 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110605, encodeId=fc751110605c1, content=RUNINGTITLE是必须的么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=512, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:54 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2021-12-29 桑晒麦拉

RUNINGTITLE是必须的么？

512 1 举报

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务